Institutional members access full text with Ovid®

Share this article on:

The 2010 Revised Classification of Seizures and Epilepsy

Berg, Anne, T.; Millichap, John, J.

CONTINUUM: Lifelong Learning in Neurology: June 2013 - Volume 19 - Issue 3, Epilepsy - p 571–597
doi: 10.1212/01.CON.0000431377.44312.9e
Review Articles

Purpose of Review: Classifications of epilepsies (1989) and seizures (1981) took a central role in epilepsy care and research. Based on nearly century-old concepts, they were abandoned in 2010, and recommendations for new concepts and terminology were made in accordance with a vision of what a future classification would entail. This review outlines the major changes, the ways these changes relate to the earlier systems, the implications for the practicing health care provider, and some of the recommendations for future classification systems.

Recent Findings: New terminology for underlying causes (genetic, structural-metabolic, and unknown) was introduced to replace the old (idiopathic, symptomatic, and cryptogenic) in 2010. The use of generalized and focal to refer to the underlying epilepsy was largely abandoned, but the terms were retained in reference to mode of seizure initiation and presentation. The terms “complex” and “simple partial” for focal seizures were abandoned in favor of more descriptive terms. Electroclinical syndromes were highlighted as specific epilepsy diagnoses and distinguished from nonsyndromic-nonspecific diagnoses. The importance of diagnosis (a clinical goal focused on the individual patient) over classification (an intellectual system for organizing information) was emphasized.

Summary: Accurate description and diagnosis of the seizures, causes, and specific type of epilepsy remain the goal in clinical epilepsy care. While terminology and concepts are being revised, the implications for patient care currently are minimal; however, the gains in the future of clear, accurate terminology and a multidomain classification system could potentially be considerable.

Address correspondence to Dr Anne T. Berg, Ann & Robert H. Lurie Children’s Hospital of Chicago Epilepsy Center, 225 East Chicago St, Box 29, Chicago, IL 60611,

Relationship Disclosure: Dr Berg has served as a speaker for BIAL; serves on an Advisory Panel for Eisai Co, Ltd; serves on the editorial boards of Neurology and Epilepsy & Behavior; and receives grants from the National Institute of Neurological Disorders and Stroke and the Pediatric Epilepsy Research Foundation. Dr Millichap serves as a section editor for Neurology and receives funding from CURE: Citizens United for Research in Epilepsy and the Thrasher Research Fund.

Unlabeled Use of Products/Investigational Use Disclosure: Drs Berg and Millichap report no disclosures.

© 2013 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website